BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37793886)

  • 1. N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin.
    Terada A; Tsuda N; Tasaki S; Park J; Nasu H; Tasaki K; Katsuda T; Nishio S; Yamaguchi T; Sanada S; Akiba J; Kuwano M; Ono M; Ushijima K
    Kurume Med J; 2023 Nov; 69(1.2):39-46. PubMed ID: 37793886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1).
    Chen Z; Zhang D; Yue F; Zheng M; Kovacevic Z; Richardson DR
    J Biol Chem; 2012 May; 287(21):17016-17028. PubMed ID: 22453918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
    Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
    Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
    Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome.
    Zhang SB; Song SP; Li B; Zhou YS; Zhang YD
    Med Oncol; 2012 Sep; 29(3):1866-72. PubMed ID: 21735144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells.
    Tu LC; Yan X; Hood L; Lin B
    Mol Cell Proteomics; 2007 Apr; 6(4):575-88. PubMed ID: 17220478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-myc downstream regulated gene 1 suppresses osteoblast differentiation through inactivating Wnt/β-catenin signaling.
    Shi X; Cen Y; Shan L; Tian L; Zhu E; Yuan H; Li X; Liu Y; Wang B
    Stem Cell Res Ther; 2022 Feb; 13(1):53. PubMed ID: 35120575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
    Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
    PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4.
    Jin R; Liu W; Menezes S; Yue F; Zheng M; Kovacevic Z; Richardson DR
    J Cell Sci; 2014 Jul; 127(Pt 14):3116-30. PubMed ID: 24829151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.
    Nishio S; Ushijima K; Tsuda N; Takemoto S; Kawano K; Yamaguchi T; Nishida N; Kakuma T; Tsuda H; Kasamatsu T; Sasajima Y; Kage M; Kuwano M; Kamura T
    Cancer Lett; 2008 Jun; 264(1):36-43. PubMed ID: 18281151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
    Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
    Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
    Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
    World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.
    Kaur J; Sawhney M; DattaGupta S; Shukla NK; Srivastava A; Walfish PG; Ralhan R
    PLoS One; 2013; 8(6):e67361. PubMed ID: 23840677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
    Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
    World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1).
    Jiang K; Shen Z; Ye Y; Yang X; Wang S
    Scand J Gastroenterol; 2010 Aug; 45(7-8):898-908. PubMed ID: 20388062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.